Drug details

Kengreal (cangrelor for injection)

type of Anticoagulants, Cardiovascular

Kengreal (cangrelor) is antiplatelet agent used as an adjunct to percutaneous coronary intervention (PCI) for reducing the risk of periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST) in patients in who have not been treated with a P2Y12 platelet inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• severe dizziness,
• severe bleeding, and
• shock

The following drugs are related to Kengreal, either as a replacement or used together:

• Durlaza (aspirin capsules)